Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03362957 · ClinicalTrials.gov registry record · NA
Geniculate Artery Embolization for Knee Pain Secondary to Osteoarthritis (OA)
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03362957 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 21 participants.
The verdict
NCT03362957, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Purpose: To evaluate embolization as a treatment for OA related knee pain versus placebo to demonstrate the actual effect of embolization on pain and disability. Participants: There will be 21 subjects enrolled over the age 40 with knee pain secondary to arthritis. Procedures (methods): This will be a single-blinded randomized-controlled study of GAE versus placebo in a small population with knee pain secondary to arthritis to determine safety and efficacy. Clinical procedures and evaluations will consist of a preoperative screening assessment to determine if the potential study subject meets the inclusion and exclusion criteria, enrollment, surgical procedure for geniculate artery embolization, and follow-up visits at 24 hours, 2 weeks, 1, 3, 6, \& 12 months. An MRI may be performed after the 1-month visit.
Interventions
- DEVICE Geniculate Artery Embolization
- DIAGNOSTIC_TEST Sham Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-05-25 |
| Est. Completion | 2020-04-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03362957
The ClinicalTrials.gov registry entry for NCT03362957 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Geniculate Artery Embolization is the first listed.
NCT03362957 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03362957 about?
NCT03362957 is a clinical study titled "Geniculate Artery Embolization for Knee Pain Secondary to Osteoarthritis (OA)". Purpose: To evaluate embolization as a treatment for OA related knee pain versus placebo to demonstrate the actual effect of embolization on pain and disability. Participants: There will be 21 subjects enrolled over the age 40 with knee pain secondary to arthritis. Procedures (methods): This will ...
What is the current status of trial NCT03362957?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2018-05-25. Estimated completion is 2020-04-24.
What interventions are being tested in trial NCT03362957?
The interventions under investigation include: Geniculate Artery Embolization (DEVICE), Sham Procedure (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03362957?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.